Data is not available at this time.
Nissha Co., Ltd. operates as a diversified technology company with core competencies in industrial materials, printed electronics, and medical device solutions. Its revenue model is anchored in high-value manufacturing and design services, leveraging in-mold decoration, sensing technologies, and metallized paper applications for packaging and automotive markets. The company serves global clients across smartphones, healthcare, and consumer goods, positioning itself as a niche innovator in functional materials and precision components. Nissha’s market strength lies in its integration of design, materials science, and electronics, enabling differentiated solutions for industries requiring advanced surface finishes or embedded sensors. With a legacy in printing technology, it has evolved into a cross-sector enabler, particularly in high-growth areas like smart surfaces and medical device outsourcing. The company’s Kyoto-based R&D focus and Japan-centric manufacturing underscore its technical rigor, though international expansion remains a strategic lever.
Nissha reported revenue of ¥195.6 billion for FY2024, with net income of ¥3.86 billion, reflecting a net margin of approximately 2%. Operating cash flow stood at ¥12.31 billion, offset by capital expenditures of ¥6.71 billion, indicating moderate reinvestment needs. The diluted EPS of ¥80.14 suggests efficient capital allocation relative to its market cap.
The company’s earnings are driven by its industrial materials and devices segments, with medical technologies contributing to higher-margin streams. A beta of 0.574 indicates lower volatility than the broader market, possibly due to diversified end-market exposure. Operating cash flow covers capital expenditures, but net income margins remain slim, signaling competitive pressures or R&D intensity.
Nissha maintains a solid liquidity position with ¥50.97 billion in cash and equivalents, against total debt of ¥72.78 billion. The debt level is manageable given its ¥59.36 billion market cap and stable cash flow generation. The balance sheet reflects a balanced approach to growth financing, with no immediate solvency concerns.
Growth is likely tied to adoption of its sensing technologies and medical device outsourcing. A dividend of ¥50 per share implies a yield of ~1.6% (assuming current share price), aligning with conservative payout policies common in Japanese industrials. The focus on high-tech applications may drive future revenue diversification.
At a market cap of ¥59.36 billion, Nissha trades at ~0.3x revenue and ~15x net income, suggesting modest expectations. The low beta implies investor perception of stability, but premium valuation hinges on execution in higher-growth segments like medical technologies.
Nissha’s strengths include its patented in-mold electronics and cross-industry applicability. Challenges include margin compression in competitive segments. The outlook depends on scaling medical device solutions and automotive sensor adoption, with R&D and global partnerships as key enablers.
Company filings, Bloomberg
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |